News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
738,007 Results
Type
Article (45138)
Company Profile (314)
Press Release (692539)
Multimedia
Podcasts (96)
Webinars (20)
Section
Business (206477)
Career Advice (2050)
Deals (35750)
Drug Delivery (131)
Drug Development (82191)
Employer Resources (174)
FDA (16607)
Job Trends (15093)
News (349422)
Policy (33036)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2680)
Accelerated approval (47)
Adcomms (29)
Allergies (170)
Alliances (50135)
ALS (206)
Alzheimer's disease (1779)
Antibody-drug conjugate (ADC) (433)
Approvals (16950)
Artificial intelligence (642)
Autoimmune disease (256)
Automation (52)
Bankruptcy (366)
Best Places to Work (11729)
BIOSECURE Act (21)
Biosimilars (217)
Biotechnology (215)
Bladder cancer (185)
Brain cancer (73)
Breast cancer (726)
Cancer (5697)
Cardiovascular disease (458)
Career advice (1737)
Career pathing (41)
CAR-T (324)
CDC (55)
Celiac Disease (3)
Cell therapy (869)
Cervical cancer (46)
Clinical research (71036)
Collaboration (2039)
Company closure (6)
Compensation (1343)
Complete response letters (81)
COVID-19 (2771)
CRISPR (108)
C-suite (1083)
Cystic fibrosis (152)
Data (7574)
Decentralized trials (3)
Denatured (28)
Depression (158)
Dermatology (77)
Diabetes (576)
Diagnostics (6970)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (314)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (279)
Earnings (91845)
Editorial (64)
Employer branding (21)
Employer resources (153)
Events (120263)
Executive appointments (1069)
FDA (20235)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (35)
Funding (1694)
Gene editing (240)
Generative AI (55)
Gene therapy (718)
GLP-1 (1045)
Government (4757)
Grass and pollen (7)
Guidances (403)
Healthcare (19108)
HIV (80)
Huntington's disease (57)
IgA nephropathy (93)
Immunology and inflammation (283)
Immuno-oncology (86)
Indications (175)
Infectious disease (3106)
Inflammatory bowel disease (208)
Inflation Reduction Act (14)
Influenza (135)
Intellectual property (284)
Interviews (324)
IPO (16730)
IRA (50)
Job creations (3686)
Job search strategy (1444)
JPM (60)
Kidney cancer (18)
Labor market (96)
Layoffs (570)
Leadership (37)
Legal (8023)
Liver cancer (101)
Longevity (32)
Lung cancer (757)
Lymphoma (422)
Machine learning (59)
Management (59)
Manufacturing (993)
MASH (180)
Medical device (13918)
Medtech (14016)
Mergers & acquisitions (20231)
Metabolic disorders (1466)
mRNA (206)
Multiple sclerosis (183)
NASH (17)
Neurodegenerative disease (402)
Neuropsychiatric disorders (104)
Neuroscience (3259)
Neurotech (1)
NextGen: Class of 2026 (6609)
Non-profit (4610)
Now hiring (76)
Obesity (686)
Opinion (292)
Ovarian cancer (209)
Pain (248)
Pancreatic cancer (290)
Parkinson's disease (353)
Partnered (33)
Patents (583)
Patient recruitment (646)
Peanut (61)
People (59995)
Pharmaceutical (62)
Pharmacy benefit managers (32)
Phase 1 (22215)
Phase 2 (31271)
Phase 3 (23263)
Pipeline (7931)
Policy (311)
Postmarket research (2592)
Preclinical (9501)
Press Release (67)
Prostate cancer (291)
Psychedelics (54)
Radiopharmaceuticals (319)
Rare diseases (1083)
Real estate (6027)
Recruiting (70)
Regulatory (25480)
Reports (55)
Research institute (2517)
Resumes & cover letters (356)
Rett syndrome (36)
RNA editing (21)
RSV (88)
Schizophrenia (176)
Series A (285)
Series B (209)
Service/supplier (13)
Sickle cell disease (115)
Special edition (23)
Spinal muscular atrophy (176)
Sponsored (47)
Startups (3703)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (88)
The Weekly (65)
Vaccines (1094)
Venture capital (106)
Weight loss (443)
Women's health (120)
Worklife (20)
Date
Today (210)
Last 7 days (768)
Last 30 days (2855)
Last 365 days (30461)
2026 (10643)
2025 (30389)
2024 (35506)
2023 (40353)
2022 (51561)
2021 (56067)
2020 (54429)
2019 (46927)
2018 (35344)
2017 (32488)
2016 (31977)
2015 (37995)
2014 (31700)
2013 (26900)
2012 (29092)
2011 (29755)
2010 (27811)
Location
Africa (768)
Alabama (91)
Alaska (7)
Arizona (343)
Arkansas (14)
Asia (40155)
Australia (6617)
California (12879)
Canada (3669)
China (1302)
Colorado (548)
Connecticut (561)
Delaware (390)
Europe (87352)
Florida (1924)
Georgia (411)
Hawaii (3)
Idaho (63)
Illinois (1025)
India (88)
Indiana (588)
Iowa (24)
Japan (514)
Kansas (129)
Kentucky (51)
Louisiana (39)
Maine (75)
Maryland (1552)
Massachusetts (9198)
Michigan (354)
Minnesota (696)
Mississippi (6)
Missouri (143)
Montana (33)
Nebraska (29)
Nevada (138)
New Hampshire (85)
New Jersey (3396)
New Mexico (29)
New York (3379)
North Carolina (1640)
North Dakota (9)
Northern California (6424)
Ohio (383)
Oklahoma (23)
Oregon (41)
Pennsylvania (2595)
Puerto Rico (28)
Rhode Island (50)
South America (1136)
South Carolina (85)
South Dakota (2)
Southern California (5058)
Tennessee (206)
Texas (2031)
United States (45543)
Utah (382)
Vermont (1)
Virginia (306)
Washington D.C. (81)
Washington State (1083)
West Virginia (4)
Wisconsin (123)
Wyoming (2)
738,007 Results for "seattle genetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
50 employees impacted as Astellas closes Universal Cells’ Seattle office
By closing the Universal Cells Seattle location, Astellas is reportedly consolidating cell therapy, gene therapy and oncology research at its South San Francisco, California, and Westborough, Massachusetts, sites.
April 14, 2026
·
2 min read
·
Angela Gabriel
Press Releases
Modular Genetics, Inc. joins New American Industrial Alliance to Reindustrialize America
March 5, 2026
·
1 min read
Press Releases
Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026
April 16, 2026
·
8 min read
Press Releases
Bionano Announces Two-Fold Increase in OGM Studies Presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
March 17, 2026
·
8 min read
Press Releases
AGC Biologics Seattle Site Now Certified to Manufacture Biologics for Largest Pharmaceutical Market in South America
February 4, 2026
·
4 min read
Press Releases
Baylor Genetics to Showcase the Impact of Early Genome Sequencing at Annual PLUGS Summit
April 17, 2026
·
2 min read
Press Releases
American College of Medical Genetics and Genomics (ACMG) Clinical Genetics Meeting: Genomics presents new research highlighting underdiagnosis of rare genetic disorders
March 12, 2026
·
3 min read
Press Releases
Opus Genetics to Participate in Leading Medical Conferences in May 2026
April 27, 2026
·
2 min read
Press Releases
Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026
April 29, 2026
·
1 min read
Press Releases
Baylor Genetics to Highlight New Data and Product Innovations at 2026 ACMG Annual Clinical Genetics Meeting
March 4, 2026
·
3 min read
1 of 73,801
Next
